{"filing":{"accession_number":"0001493152-26-029081","cik":"0000719135","ticker":"APYX","company_name":"Apyx Medical Corp","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226029081/form8-k.htm"},"events":[{"id":11533,"run_id":10129,"accession_number":"0001493152-26-029081","anchor_item_number":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"The filing discloses a letter agreement with Stavros Vizirgianakis, the Chairman, in connection with his appointment as Executive Chairman. The material substance is the Board's approval of a 450,000 RSU grant under the 2023 Share Incentive Plan with a three-tranche vesting schedule. While the appointment itself is mentioned, the filing centers on the compensatory arrangement—the equity grant—which is the principal disclosed action and would materially affect investor assessment of executive compensation and dilution.","company_name":"Apyx Medical Corp","ticker":"APYX","filing_date":"2026-06-17","submitted_at":null,"items":null}],"classifications":[{"id":8139,"accession_number":"0001493152-26-029081","item_number":null,"item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a letter agreement with Stavros Vizirgianakis, the Chairman, in connection with his appointment as Executive Chairman. The material substance is the Board's approval of a 450,000 RSU grant under the 2023 Share Incentive Plan with a three-tranche vesting schedule. While the appointment itself is mentioned, the filing centers on the compensatory arrangement—the equity grant—which is the principal disclosed action and would materially affect investor assessment of executive compensation and dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:08:35.326802+00:00","company_name":"Apyx Medical Corp","ticker":"APYX","filing_date":"2026-06-17"}]}